{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T16:51:02Z","timestamp":1761929462474},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2010,6,15]],"date-time":"2010-06-15T00:00:00Z","timestamp":1276560000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Spinal Cord"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1038\/sc.2010.68","type":"journal-article","created":{"date-parts":[[2010,6,15]],"date-time":"2010-06-15T10:09:19Z","timestamp":1276596559000},"page":"182-185","source":"Crossref","is-referenced-by-count":11,"title":["Cervical MRI of subacute myelo-optico-neuropathy"],"prefix":"10.1038","volume":"49","author":[{"given":"E","family":"Kimura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Hirano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Hirai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Uchino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,6,15]]},"reference":[{"key":"BFsc201068_CR1","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/S0140-6736(71)92699-7","volume":"1","author":"T Tsubaki","year":"1971","unstructured":"Tsubaki T, Honma Y, Hoshi M . Neurological syndrome associated with clioquinol. Lancet 1971; 1: 696\u2013697.","journal-title":"Lancet"},{"issue":"Suppl","key":"BFsc201068_CR2","first-page":"187","volume":"28","author":"J Tateishi","year":"1975","unstructured":"Tateishi J, Kuroda S, Ikeda H, Otsuki S . Neurotoxity of iodoxyquinoline: a further study on beagle dogs. Jpn J Med Sci Biol 1975; 28 (Suppl): 187\u2013195.","journal-title":"Jpn J Med Sci Biol"},{"key":"BFsc201068_CR3","first-page":"115","volume-title":"Handbook of clinical neurology","author":"I Sobue","year":"1979","unstructured":"Sobue I . Clinical aspects of subacute myelo-optico-neuropathy (SMON). In: Vinken PJ BG, Cohen MM et al (eds). Handbook of clinical neurology, vol. 37 Elsevier: Amsterdam, 1979. pp 115\u2013139."},{"key":"BFsc201068_CR4","first-page":"141","volume-title":"Handbook of Clinical Neurology","author":"H Shiraki","year":"1979","unstructured":"Shiraki H In: Vinken PJ, Bruyn GW, Cohen MM, et al. (eds). Handbook of Clinical Neurology. Elsevier: Amsterdam, 1979. pp 141\u2013198."},{"key":"BFsc201068_CR5","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/S0140-6736(71)90436-3","volume":"2","author":"K Nakae","year":"1971","unstructured":"Nakae K, Yamamoto S, Igata A . Subacute myelo-optico-neuropathy (S.M.O.N.) in Japan. A community survey. Lancet 1971; 2: 510\u2013512.","journal-title":"Lancet"},{"key":"BFsc201068_CR6","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.jns.2003.11.007","volume":"218","author":"M Konagaya","year":"2004","unstructured":"Konagaya M, Matsumoto A, Takase S, Mizutani T, Sobue G, Konishi T et al. Clinical analysis of longstanding subacute myelo-optico-neuropathy: sequelae of clioquinol at 32 years after its ban. J Neurol Sci 2004; 218: 85\u201390.","journal-title":"J Neurol Sci"},{"key":"BFsc201068_CR7","doi-asserted-by":"publisher","first-page":"217","DOI":"10.7883\/yoken1952.24.217","volume":"24","author":"H Shiraki","year":"1971","unstructured":"Shiraki H . Neuropathology of subacute myelo-optico-neuropathy, \u2018SMON\u2019. Jpn J Med Sci Biol 1971; 24: 217\u2013243.","journal-title":"Jpn J Med Sci Biol"},{"key":"BFsc201068_CR8","first-page":"162","volume":"63","author":"H Konno","year":"2005","unstructured":"Konno H, Takase S . Neuropathology of longstanding subacute myelo-optico-neuropathy (SMON)]. Shinkei Naika 2005; 63: 162\u2013169.","journal-title":"Shinkei Naika"},{"key":"BFsc201068_CR9","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1007\/s00415-006-0479-2","volume":"254","author":"M Spinazzi","year":"2007","unstructured":"Spinazzi M, De Lazzari F, Tavolato B, Angelini C, Manara R, Armani M . Myelo-optico-neuropathy in copper deficiency occurring after partial gastrectomy. Do small bowel bacterial overgrowth syndrome and occult zinc ingestion tip the balance? J Neurol 2007; 254: 1012\u20131017.","journal-title":"J Neurol"},{"key":"BFsc201068_CR10","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/ncpneuro1008","volume":"5","author":"RI Spain","year":"2009","unstructured":"Spain RI, Leist TP, De Sousa EA . When metals compete: a case of copper-deficiency myeloneuropathy and anemia. Nat Clin Pract Neurol 2009; 5: 106\u2013111.","journal-title":"Nat Clin Pract Neurol"},{"key":"BFsc201068_CR11","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1093\/postgradmedj\/81.954.227","volume":"81","author":"N Kumar","year":"2005","unstructured":"Kumar N, Knopman DS . SMON, clioquinol, and copper. Postgrad Med J 2005; 81: 227.","journal-title":"Postgrad Med J"},{"key":"BFsc201068_CR12","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1212\/01.wnl.0000324620.86645.c1","volume":"71","author":"H Schaumburg","year":"2008","unstructured":"Schaumburg H, Herskovitz S . Copper deficiency myeloneuropathy: a clue to clioquinol-induced subacute myelo-optic neuropathy? Neurology 2008; 71: 622\u2013623.","journal-title":"Neurology"},{"key":"BFsc201068_CR13","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1212\/01.wnl.0000312375.79881.94","volume":"71","author":"SP Nations","year":"2008","unstructured":"Nations SP, Boyer PJ, Love LA, Burritt MF, Butz JA, Wolfe GI et al. Denture cream: an unusual source of excess zinc, leading to hypocupremia and neurologic disease. Neurology 2008; 71: 639\u2013643.","journal-title":"Neurology"},{"key":"BFsc201068_CR14","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1212\/01.WNL.0000073542.02761.5F","volume":"61","author":"N Kumar","year":"2003","unstructured":"Kumar N, Gross Jr JB, Ahlskog JE . Myelopathy due to copper deficiency. Neurology 2003; 61: 273\u2013274.","journal-title":"Neurology"},{"key":"BFsc201068_CR15","first-page":"1303","volume":"60","author":"P Hedera","year":"2003","unstructured":"Hedera P, Fink JK, Bockenstedt PL, Brewer GJ . Myelopolyneuropathy and pancytopenia due to copper deficiency and high zinc levels of unknown origin: further support for existence of a new zinc overload syndrome. Arch Neurol 2003; 60: 1303\u20131306.","journal-title":"Arch Neurol"},{"key":"BFsc201068_CR16","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1016\/j.neuro.2009.08.008","volume":"30","author":"P Hedera","year":"2009","unstructured":"Hedera P, Peltier A, Fink JK, Wilcock S, London Z, Brewer GJ . Myelopolyneuropathy and pancytopenia due to copper deficiency and high zinc levels of unknown origin. II. The denture cream is a primary source of excessive zinc. Neurotoxicology 2009; 30: 996\u2013999.","journal-title":"Neurotoxicology"},{"key":"BFsc201068_CR17","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1007\/s004150170118","volume":"248","author":"B Schleper","year":"2001","unstructured":"Schleper B, Stuerenburg HJ . Copper deficiency-associated myelopathy in a 46-year-old woman. J Neurol 2001; 248: 705\u2013706.","journal-title":"J Neurol"},{"key":"BFsc201068_CR18","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s00234-005-0016-5","volume":"48","author":"N Kumar","year":"2006","unstructured":"Kumar N, Ahlskog JE, Klein CJ, Port JD . Imaging features of copper deficiency myelopathy: a study of 25 cases. Neuroradiology 2006; 48: 78\u201383.","journal-title":"Neuroradiology"},{"key":"BFsc201068_CR19","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/S0896-6273(01)00330-0","volume":"30","author":"GK Gouras","year":"2001","unstructured":"Gouras GK, Beal MF . Metal chelator decreases Alzheimer beta-amyloid plaques. Neuron 2001; 30: 641\u2013642.","journal-title":"Neuron"},{"key":"BFsc201068_CR20","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/S0896-6273(03)00126-0","volume":"37","author":"D Kaur","year":"2003","unstructured":"Kaur D, Yantiri F, Rajagopalan S, Kumar J, Mo JQ, Boonplueang R et al. Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: a novel therapy for Parkinson's disease. Neuron 2003; 37: 899\u2013909.","journal-title":"Neuron"}],"container-title":["Spinal Cord"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/sc201068.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/sc201068","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/sc201068.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T15:57:43Z","timestamp":1685635063000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/sc201068"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6,15]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["BFsc201068"],"URL":"https:\/\/doi.org\/10.1038\/sc.2010.68","relation":{},"ISSN":["1362-4393","1476-5624"],"issn-type":[{"value":"1362-4393","type":"print"},{"value":"1476-5624","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,6,15]]}}}